Creo Medical Group PLC
LSE:CREO
Balance Sheet
Balance Sheet Decomposition
Creo Medical Group PLC
Current Assets | 49.1m |
Cash & Short-Term Investments | 26.5m |
Receivables | 14.6m |
Other Current Assets | 8m |
Non-Current Assets | 39.6m |
Long-Term Investments | 2.1m |
PP&E | 9.7m |
Intangibles | 26.3m |
Other Non-Current Assets | 1.5m |
Current Liabilities | 11.9m |
Accounts Payable | 7.5m |
Other Current Liabilities | 4.4m |
Non-Current Liabilities | 7.8m |
Long-Term Debt | 5.6m |
Other Non-Current Liabilities | 2.2m |
Balance Sheet
Creo Medical Group PLC
Jun-2016 | Jun-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Cash & Cash Equivalents |
1
|
14
|
45
|
81
|
45
|
44
|
13
|
|
Cash Equivalents |
1
|
14
|
45
|
81
|
45
|
44
|
13
|
|
Total Receivables |
1
|
2
|
3
|
4
|
7
|
9
|
10
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
4
|
4
|
5
|
|
Other Receivables |
1
|
2
|
3
|
4
|
3
|
5
|
5
|
|
Inventory |
0
|
0
|
0
|
1
|
7
|
9
|
9
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Total Current Assets |
2
|
16
|
49
|
86
|
59
|
61
|
34
|
|
PP&E Net |
0
|
0
|
1
|
1
|
3
|
9
|
10
|
|
PP&E Gross |
0
|
0
|
1
|
1
|
3
|
9
|
10
|
|
Accumulated Depreciation |
0
|
0
|
1
|
2
|
4
|
5
|
7
|
|
Intangible Assets |
0
|
0
|
0
|
1
|
10
|
9
|
8
|
|
Goodwill |
0
|
0
|
0
|
0
|
18
|
19
|
20
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
|
Other Assets |
0
|
0
|
0
|
0
|
18
|
19
|
20
|
|
Total Assets |
2
N/A
|
16
+567%
|
50
+209%
|
88
+77%
|
92
+5%
|
101
+9%
|
75
-25%
|
|
Liabilities | ||||||||
Accounts Payable |
0
|
1
|
1
|
1
|
2
|
4
|
4
|
|
Accrued Liabilities |
0
|
1
|
1
|
4
|
4
|
5
|
4
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
6
|
5
|
3
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
6
|
6
|
4
|
|
Total Current Liabilities |
1
|
1
|
2
|
5
|
18
|
20
|
17
|
|
Long-Term Debt |
0
|
0
|
0
|
1
|
7
|
5
|
6
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
3
|
1
|
0
|
|
Total Liabilities |
1
N/A
|
1
+86%
|
2
+38%
|
6
+175%
|
30
+430%
|
27
-8%
|
26
-5%
|
|
Equity | ||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
2
|
5
|
18
|
33
|
52
|
74
|
100
|
|
Additional Paid In Capital |
0
|
20
|
66
|
115
|
115
|
149
|
150
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
|
Total Equity |
2
N/A
|
15
+799%
|
48
+226%
|
83
+73%
|
63
-24%
|
73
+17%
|
49
-33%
|
|
Total Liabilities & Equity |
2
N/A
|
16
+567%
|
50
+209%
|
88
+77%
|
92
+5%
|
101
+9%
|
75
-25%
|
|
Shares Outstanding | ||||||||
Common Shares Outstanding |
84
|
84
|
125
|
156
|
164
|
188
|
188
|